Oestrogel (Estradiol)

Estradiol, the active ingredient in Oestrogel, is an estrogen presented as a transdermal gel for transdermal use. It restores estrogenic activity in target tissues, alleviating menopausal symptoms, treating estrogen deficiency and managing hypoestrogenism in post‑menopausal women and other estrogen‑dependent conditions. It is indicated for relief of vasomotor symptoms, prevention of bone loss, and improvement of urogenital atrophy.

GNH USA supplies Oestrogel as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, transplant centres and clinics worldwide under strict quality standards and regulatory compliance. The company adheres to Good Distribution Practice and supports procurement needs with reliable logistics.

Oestrogel (estradiol) is used in hormone replacement therapy to address estrogen‑dependent conditions. - Menopausal symptoms: Reduces hot flashes, night sweats and improves sleep and mood disturbances. - Estrogen deficiency: Restores systemic estrogen levels, supporting bone health and preventing osteoporosis progression. - Hypoestrogenism: Provides physiological estrogen replacement in women with low endogenous production, aiding urogenital tissue health. - Urogenital atrophy: Improves vaginal dryness and urinary symptoms by enhancing mucosal integrity.

Common Side Effects: - Skin irritation at the application site: Redness, itching or rash where the gel is applied. - Headache: Mild to moderate intensity, often transient. - Breast tenderness: Sensitivity or swelling of breast tissue. - Nausea: Mild gastrointestinal discomfort. - Mild abdominal cramps: Intermittent lower abdominal discomfort. - Increased vaginal discharge: Slight change in vaginal secretions.

Serious or Rare Side Effects: - Deep vein thrombosis: Formation of blood clots in deep veins, potentially life‑threatening. - Pulmonary embolism: Blockage of pulmonary arteries by a clot. - Stroke: Cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: Heart attack resulting from coronary artery blockage. - Severe allergic reaction: Anaphylaxis, swelling, or hives. - Hepatic dysfunction: Elevated liver enzymes or liver injury.

Before initiating Oestrogel, consider the following precautions: - Assess cardiovascular risk: Review history of thromboembolic disease, stroke, or myocardial infarction before use. - Monitor for breast changes: Conduct regular breast examinations and imaging as indicated. - Evaluate liver function: Check hepatic status in patients with known liver disease. - Caution in pregnancy: Avoid use in women who are pregnant or may become pregnant. - Interact with other hormones: Use with caution when combined with progestogens or other estrogenic agents. - Store at room temperature: Keep gel below 25 °C, in original container, protected from light and moisture.

Oestrogel may interact with several medicines. Review the following before prescribing: Major Interactions (Avoid): - Oral anticoagulants: May increase risk of thrombosis. - Selective serotonin reuptake inhibitors: Potentially heightened bleeding risk. - Hormonal contraceptives: Additive estrogen effect may raise thrombotic risk. Moderate Interactions (Monitor Closely): - Thyroid hormones: Estradiol can increase thyroid‑binding globulin, altering hormone levels. - Antifungal azoles: May inhibit estradiol metabolism, increasing plasma concentrations. - Antiepileptic drugs: Enzyme‑inducing agents can reduce estradiol efficacy.